Junctional Adhesion Molecule-Like Protein Promotes Tumor Progression and Metastasis P38 Signaling Pathway in Gastric Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Mar 29

PMID 33777731

Citations 8

Authors

Yuying Fang

Jianmin Yang

Guohong Zu

Changsheng Cong

Shuai Liu

Fei Xue

Shuzhen Ma

Jie Liu

Yuping Sun

Meili Sun

Affiliations

Soon will be listed here.

Abstract

Junctional adhesion molecule-like protein (JAML), a newly discovered junctional adhesion molecule (JAM), mediates the adhesion and migration processes of various immune cells and endothelial/epithelial cells, ultimately regulating inflammation reaction. However, its role in tumors remains to be determined. The expression of JAML was examined in gastric cancer (GC) and peritumoral tissues from 63 patients. The relationship between JAML expression and clinical characteristics was also observed. , GC cell migration and proliferation were assessed by wound healing assay, transwell migration assay and EdU incorporation assay. Immunohistochemical staining results showed that JAML expression level was higher in GC tissues than in peritumoral tissues. High expression of JAML in cancer tissues was associated with worse cell differentiation, local lymph node involvement, deep infiltration, and advanced stage. , we found that JAML silencing inhibited GC cell migration and proliferation, while JAML overexpression promoted GC cell migration and proliferation, partially p38 signaling. Taken together, our study revealed a critical role for JAML to promote GC cell migration and proliferation. JAML might be a novel diagnostic biomarker and therapeutic target for GC.

Citing Articles

JAML overexpressed in colorectal cancer promotes tumour proliferation by activating the PI3K-AKT-mTOR signalling pathway.

Fang Y, Liu Y, Dong Z, Zhao X, Zhang M, Zheng Y Sci Rep. 2024; 14(1):24514.

PMID: 39424882 PMC: 11489459. DOI: 10.1038/s41598-024-75180-z.

Endogenous retroviruses are dysregulated in ALS.

Pasternack N, Doucet-OHare T, Johnson K, Paulsen O, Nath A iScience. 2024; 27(7):110147.

PMID: 38989463 PMC: 11233923. DOI: 10.1016/j.isci.2024.110147.

PSKH1 affects proliferation and invasion of osteosarcoma cells via the p38/MAPK signaling pathway.

Zhu X, Jiang C, Wang Z, Zhu X, Yuan F, Yang Y Oncol Lett. 2023; 25(4):144.

PMID: 36936027 PMC: 10018237. DOI: 10.3892/ol.2023.13730.

Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.

Wu Q, Li R, Wang Q, Zhang M, Liu T, Qu Y J Transl Med. 2022; 20(1):260.

PMID: 35672776 PMC: 9171988. DOI: 10.1186/s12967-022-03457-w.

SAMHD1, positively regulated by KLF4, suppresses the proliferation of gastric cancer cells through MAPK p38 signaling pathway.

Chen Z, Jiang Z, Meng L, Wang Y, Lin M, Wei Z Cell Cycle. 2022; 21(19):2065-2078.

PMID: 35670736 PMC: 9467599. DOI: 10.1080/15384101.2022.2085356.

References

Guo Y, Bai R, Chen C, Liu D, Liu Y, Zhang C . Role of junctional adhesion molecule-like protein in mediating monocyte transendothelial migration. Arterioscler Thromb Vasc Biol. 2008; 29(1):75-83. DOI: 10.1161/ATVBAHA.108.177717. View

Luissint A, Lutz P, Calderwood D, Couraud P, Bourdoulous S . JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation. J Cell Biol. 2008; 183(6):1159-73. PMC: 2600739. DOI: 10.1083/jcb.200805061. View

Verdino P, Witherden D, Havran W, Wilson I . The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K. Science. 2010; 329(5996):1210-4. PMC: 2951132. DOI: 10.1126/science.1187996. View

Del Barco Barrantes I, Nebreda A . Roles of p38 MAPKs in invasion and metastasis. Biochem Soc Trans. 2012; 40(1):79-84. DOI: 10.1042/BST20110676. View

Fuse C, Ishida Y, Hikita T, Asai T, Oku N . Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma. J Biol Chem. 2007; 282(11):8276-83. DOI: 10.1074/jbc.M608836200. View

Zhu M, Wang Q, Luo Z, Liu K, Zhang Z . Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients. Onco Targets Ther. 2018; 11:8711-8722. PMC: 6287660. DOI: 10.2147/OTT.S181741. View

McSherry E, McGee S, Jirstrom K, Doyle E, Brennan D, Landberg G . JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer. 2009; 125(6):1343-51. DOI: 10.1002/ijc.24498. View

Cuadrado A, Nebreda A . Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010; 429(3):403-17. DOI: 10.1042/BJ20100323. View

Weber D, Sumagin R, McCall I, Leoni G, Neumann P, Andargachew R . Neutrophil-derived JAML inhibits repair of intestinal epithelial injury during acute inflammation. Mucosal Immunol. 2014; 7(5):1221-32. PMC: 4340686. DOI: 10.1038/mi.2014.12. View

10.

Amin M, Greene F, Edge S, Compton C, Gershenwald J, Brookland R . The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017; 67(2):93-99. DOI: 10.3322/caac.21388. View

11.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

12.

Moog-Lutz C, Cave-Riant F, Guibal F, Breau M, Di Gioia Y, Couraud P . JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells. Blood. 2003; 102(9):3371-8. DOI: 10.1182/blood-2002-11-3462. View

13.

Garrido-Urbani S, Vonlaufen A, Stalin J, De Grandis M, Ropraz P, Jemelin S . Junctional adhesion molecule C (JAM-C) dimerization aids cancer cell migration and metastasis. Biochim Biophys Acta Mol Cell Res. 2018; 1865(4):638-649. DOI: 10.1016/j.bbamcr.2018.01.008. View

14.

Witherden D, Verdino P, Rieder S, Garijo O, Mills R, Teyton L . The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science. 2010; 329(5996):1205-10. PMC: 2943937. DOI: 10.1126/science.1192698. View

15.

Hamidi H, Ivaska J . Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018; 18(9):533-548. PMC: 6629548. DOI: 10.1038/s41568-018-0038-z. View

16.

Han J, Sun P . The pathways to tumor suppression via route p38. Trends Biochem Sci. 2007; 32(8):364-71. DOI: 10.1016/j.tibs.2007.06.007. View

17.

Dhillon A, Hagan S, Rath O, Kolch W . MAP kinase signalling pathways in cancer. Oncogene. 2007; 26(22):3279-90. DOI: 10.1038/sj.onc.1210421. View

18.

Zen K, Liu Y, McCall I, Wu T, Lee W, Babbin B . Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. Mol Biol Cell. 2005; 16(6):2694-703. PMC: 1142417. DOI: 10.1091/mbc.e05-01-0036. View

19.

Sun Y, Guan J, Hou Y, Xue F, Huang W, Zhang W . Silencing of junctional adhesion molecule-like protein attenuates atherogenesis and enhances plaque stability in ApoE mice. Clin Sci (Lond). 2019; 133(11):1215-1228. DOI: 10.1042/CS20180561. View

20.

Tenan M, Aurrand-Lions M, Widmer V, Alimenti A, Burkhardt K, Lazeyras F . Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma. Glia. 2009; 58(5):524-37. DOI: 10.1002/glia.20941. View